7. MANAGEMENT
● Conservative : reassurance,cool mist and oral
hydration
● Nebulized epinephrine ( 1:1000 dilution 0.1- 0.5
ml/kg, to a maximum of 5 mL) provide
symptomatic relief
● single dose of dexamethasone (0.3-0.6 mg/kg,
intramuscular) reduces severity, if given within the
first 24 hours.
● Inhaled budesonide (1 mg twice a day for two
days)
antibiotics against Staphylococcus and H. influenzae
are indicated, if the child fails to improve .
8. ACUTE EPIGLOTTITIS
● Serious illness
● Age group:-3 to 6 years
● Etiology:H.influenzae type b
● Clinical features: sudden onset high
grade fever, sore throat, muffled voice,
inspiratory stridor, dysphagia.
Releiving factor:Child Sits in a leaning
forward position “tripod position” with
his neck extended and saliva dribbling.
9. DIAGNOSIS:
Airway management - Intubation or Rigid
broncoscopy , followed by tracheostomy
Humidified oxygen by hood, fluids to maintain
hydration, Ceftriaxone or cefotaxime 100mg/kg/day
for 7 days
Atypical presentation:
Flexible endoscopy – edema,erythema of supraglottic
structures
11. RETROPHARYNGEAL ABSCESS
• Etiology:complication of bacterial pharyngitis or
dental infection, with abscess formation in
lymph nodes between the pharynx and
prevertebral fascia
• Clinical features:high fever, stridor, drooling and
reduced neck mobility.
• Complication:Spread to the mediastinum is
fatal.
12.
13. Management:
● parenteral antibiotics
● surgical drainage of abscess by transoral or
transcervical approach.
● Tracheostomy may be necessary to secure the
airway.
14. Bacterial tracheitis
Etiology: S. aureus, affects younger children and
follows a viral upper respiratory tract infection.
The child appears toxic ,brassy cough with biphasic
or expiratory stridor.
X-ray neck shows an irregular tracheal wall.
Diagnosis:Bronchoscopy ; culture and removal of
purulent tracheal secretions.
15. LARYNGOMALACIA
Most common congenital anomaly
Chief cause of chronic stridor in infancy
Clinical features: inspiratory stridor; increase in supine or crying
position
Flexible endoscopy:
● Omega shaped epiglottis
● Short aryepiglottic folds
● Partial collapse of a flaccid supraglottic airway with
inspiration
16.
17. Management
Benign and self limiting
Resolve by 18 months
Surgical intervention include : Temporary Tracheostomy or
supraglottoplasty is done in case of severe respiratory
distress.
Concomitant gastroesophageal reflux should be managed
medically.
18. VOCAL CORD PARALYSIS
Second most common congenital laryngeal anomaly
Causes:
● excessive stretching of the neck during vaginal
delivery
● Injury to Left recurrent laryngeal Nerve in
surgery of PDA
● Idiopathic
● Associated with hypoxia ,hydrocephalus and
Arnold Chiari malformation
19. Clinical features:
● Bilateral cord palsy: high pitched inspiratory stridor
and cyanosis
● Unilateral cord palsy:mild stridor ,weak cry
Chance of aspiration in case of vagus nerve paralysis
21. ACQUIRED SUBGLOTTIC STENOSIS
● Most common cause of acquired stridor, follows
long term endotracheal intubation
● Mucosal Trauma and inflammation of subglottis
leads to scarring
● Clinical feature : progressive biphasic stridor after
extubation
22. Management
● Minor stenosis requires careful observation
● severe stenosis requires release of stenosis with CO₂
laser and dilatation, widening with cartilage grafts or
excision of stenotic segment, with tracheotomy
● Special T-shaped silicone tracheostomy tubes are
used for temporary stenting until complete healing.
23. ● In prolonged intubation , early tracheotomy
prevents the complication of post-intubation
subglottic stenosis.
● cuffed tracheostomy tubes should be
avoided in children; if a cuffed tube is
essential, intermittent deflation is advised.
24. FOREIGN BODY ASPIRATION
● Considered in acute onset stridor and airway obstruction
in children
● If not expelled by coughing it migrates to lower airway,
Lodging in the subglottic region
● In case of small FB, they lodge in secondary bronchioles
and later - presents with pneumonia
● Management is by rigid bronchoscopy for FB removal,
lavage to clear up secretions and antibiotics.
25. WHEEZING
● High pitched whistling sound audible without
auscultation.
● Partial obstruction of bronchi and bronchioles
leading to narrowing produces wheezing.
● Due to causes within lumen or in walls of bronchi
27. BRONCHIAL ASTHMA
Chronic inflammatory disease of airways characterized by
increased responsiveness of the airways to various stimuli
and reversible diffuse airway obstruction .
Pathophysiology
Edema and inflammation of mucous membrane lining
Excessive secretions of mucus, inflammatory cells and
cellular debris
Spasm of smooth muscle of bronchi.
30. CLINICAL FEATURES
Cold or bouts of non productive cough
Wheezing and dyspnea ,with prolonged expiration
Cyanosis, Pulsus paradoxus and cardiac arrythmias
indicate severe illness.
Child sweats profusely and is apprehensive and
restless.
31. Child shows air hunger and fatigue.
Hyperresonant chest
severe obstruction : feeble breath sounds
,wheezing disappears.
Chronic intermittent cases:barrel shaped
chest
32. DIAGNOSIS
Clinical
Family h/o asthma or atopic dermatitis or allergic
rhinitis
Recurrent episodes that resolved
Relatively afebrile episode
Presence of trigger factors :nocturnal or seasonal
exacerbations,exercise induced
Clear and mucoid sputum sometimes yellow.
33. INVESTIGATIONS
Absolute Eosinophil count
Chest Xray: b/l and symmetric air trapping, Patches of
atelectasis,Prominent main pulmonary artery due to
pulmonary hypertension.
Pulmonary function test – PEFR{peak expiratory flow
rate},FEV1{forced expiratory volume},FVC{forced vital
capacity} and FEV25-75 - decreased
Allergy tests
34. PEAK EXPIRATORY FLOW RATE (PEFR)
Measured with flow meter
Reduced in acute attacks and 15%reduced after
exercise challenge
Abnormalities
Diurnal variation of >20% , <80% of predicted
Improvement of >20% after bronchodilator therapy
35. SPIROMETRY
• Useful only in children above 6 years
• FEV1 (the amount of air that can be expelled
in the first second of forced expiration) is
reduced.
• FEV1/FVC <80% indicates airflow obstruction
and improvement of FEV1 by >12% or 200 ml
after bronchodilators indicates reversibility of
the airflow obstruction.
36. The flow volume
loop shows
concavity in the
expiratory flow
volume loop
(obstruction to
expiratory flow).
37.
38.
39. ALLERGY TEST
Skin test to identify sensitivity to different
antigens.
RAST(radioallergosorbent allergen specific Ig E)
Test
Not diagnostic, limited use.
Blood IgE levels may be raised in children with
atopic asthma, but is not diagnostic.
40. Bronchial asthma cannot be cured but can be controlled.
Goals of therapy are:
(1) maintain near normal pulmonary function;
(ii) maintain near normal physical activity;
(iii) prevent nighttime cough or wheezing with minimal
chronic symptoms;
(iv) prevent recurrences;
(v) avoid adverse effects of therapy
41. Effective long-term management of asthma involves three
major areas:
i. Identification and elimination of exacerbating factors
ii. Pharmacological therapy
iii. Education of patient and parents about nature of disease
and steps to avoid acute exacerbation
42. IDENTIFY AND ELIMINATE EXACERBATING FACTORS
Following measures may help in reducing risk of
recurrences:
i. The bedroom- clean and free from dust. Wet
mopping of the floor is encouraged.
ii. Since heavy tapestry attracts dust, light plain cloth
sheet to be used as curtains in the child's bedroom.
iii. Periodic cleaning of carpets, stuffed furniture, loose
clothing and hangings, calendars and books.
43. iv. The child's bed should be made of light
material and aired regularly.
v.Caressing of animal pets is discouraged, as
the child may be sensitive to their fur.
vi. It is usually not necessary to restrict the
diet, since food allergy is not the cause in
most cases.
44. vii. Adolescent patients should refrain from
smoking.
viii. Exposure to strong odors such as wet
paint,
disinfectants and smoke should be
minimized.
ix. The child should avoid attics or
basements, especially if unoccupied and
closed.
46. Pharmacological management
Key steps are :
• Assessment of symptom control
• Assessment of risk of exacerbation
• Selection of medication
• Selection of appropriate inhalational
device
• Monitoring
47.
48.
49. SELECTION OF APPROPRIATE INHALATION
DEVICE
• Children <4-year-old: MDI with spacer
with
face mask
• Children >4-year-old: MDI with spacer
preferred
• Children>12-year-old: MDI used
directly.
Use of spacer improves drug
deposition.
50. Monitoring and Modification of Treatment
• After initiating treatment, patients should be
seen every 4 -12 weeks.
• history regarding frequency of symptoms,
sleep disturbance, physical activity, school
absenteeism, visit to a doctor and need for
bronchodilators, and PEFR is recorded.
• The inhalation technique and compliance is
checked.
51. • Patient is assessed as controlled, partially
controlled or uncontrolled.
• If partially controlled or uncontrolled, cause
mostly would be poor compliance, wrong
technique, Associated infections,
inappropriate doses etc,
• If no cause detected then step up
• Step down - control is Sustained for 3-6
Months.
52. • Description of asthma in plain language should
be made.
• The spectrum of severity of the illness, likely
course and satisfactory outcome is explained.
• Avoiding environmental triggers
• Avoidance of all kinds of smoke at home,
including tobacco smoke, wood burning and
kerosene stove is emphasized.
Education of parents
55. MILD ACUTE ASTHMA
cough, rapid respiration and some wheezing, but
no chest indrawing . speaks and drink well.
PEFR >80% of predicted ; oxygen saturation >95%
in room air.
● Give ß₂ agonists by nebulizer or MDI + spacer
with or without face mask. If MDI is used, one
puff of the agonist is given every minute for up
to 10 puffs.
56. • If case of significant improvement,sent
home on inhalation or oral B₂ agonists
every 6-8 hours
• Review After 1-2 weeks for reassessment
and long term treatment.
• In case of unsatisfactory response, the
patient should be treated as moderate
exacerbation.
57. ACUTE, MODERATE AND SEVERE
rapid respiration, chest indrawing, wheezing, pulsus
paradoxus, difficulty in speech and feeding; PEFR and
oxygen saturation is decreased and sensorium is normal.
● Patients should receive inhalation B2, agonist as
described for treatment of mild asthma.
● Oxygen inhalation is started and oral prednisolone 1-2
mg/kg administered. The patient is assessed for
improvement at the end of 1 hour.
58. ● Improvement, continued on inhaled B₂
agonists every 30 minutes, and the interval
gradually increased to 4-6 hourly.
● Oxygen inhalation is stopped, if patient is
able to maintain oxygen saturation >95%.
● Prednisolone is continued once daily for 5-
7 days, and then stopped without tapering.
59. ● The patient is discharged from hospital when the
need for bronchodilators is every 4-6 hours, able
to feed and speak well, maintains oxygen
saturation >95% in room air and PEFR >75% of
predicted.
● These patients should be educated about the
disease, need for regular follow-up and avoidance
of triggers.
● They should be assessed for long-term treatment.
60. ● No improvement at the end of 1 hour,
inhalation of salbutamol is continued and
inhaled ipratropium 250 mg given every 20
minutes.
● An injection of hydrocortisone 10 mg/kg is
given and reassessed at end of 2 hours. If
satisfactory response is obtained, the patient is
treated like early responders.
● If case of no response, IV theophylline bolus is
followed by continuous infusion.
61. • Such patients respond well to magnesium
infusion at a dose of 50 mg/kg (with dextrose
over 30 minutes). If no improvement :possible
mechanical ventilation.
• transfer to an intensive care unit include
worsening hypoxia or hypercapnia,
exhaustion, feeble respiration, confusion,
drowsiness, coma or respiratory arrest.
62. BRONCHIOLITIS
• Occurs with in first 2 years, highest incidence in first 6
months.
• Usually in winter Or spring
• Repeated attack indicate viral infection (RSV)
associated with wheezing, or asthma.
• Chest xray shows hyperinflation with scattered areas
of infiltration.
• Infants with bronchiolitis and atopic dermatitis, high
IgE levels Or family history of allergy need follow up
for later development of asthma
64. ASPIRATION OF FOREIGN BODY
• Cause localized area of wheezing, hyperresonance
and reduced air entry.
• History of aspiration may be forgotten.
• Frequent infection in lung may occur.
CYSTIC FIBROSIS
• Recurrent wheezing, clubbing and malabsorption.
• X ray chest shows hyperinflation, peribronchial
cuffing and pneumonia.